Home » Topics » Regulatory

Regulatory
RSS

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Timentin cleared for pediatric use in U.S.

Jan. 22, 1998

Pfizer to develop Nastech formulation of sleep aid

Jan. 21, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...